Literature DB >> 35733030

Amphicrine Medullary Thyroid Carcinoma - a Case-Based Review Expanding on Its MUC Expression Profile.

Hena Khandakar1, Shipra Agarwal2, Mehar Chand Sharma1, Devasenathipathy Kandasamy3, Chandrasekhar Bal4, Yashvant Rathode5, Rijuta Aphale5.   

Abstract

Amphicrine phenotype in medullary thyroid carcinoma (MTC) is a rare phenomenon characterized by tumor cells that show both endocrine differentiation (calcitonin secretion) and exocrine differentiation (mucin production and secretion). Not much is known about the pathobiology of amphicrine MTCs. This report undertook a case-based review approach by discussing the cytological, histopathological, and ultrastructural features of this rare enigmatic entity, expanding on the radiological and novel MUC immunohistochemistry findings from a 28-year-old MEN2B syndrome patient with C cell hyperplasia and multifocal MTC with amphicrine features. The patient had widespread hematogenous metastases at presentation. MUC immunoexpression analysis revealed evidence of micro-lumina formation, and unique to-date unreported expression patterns of MUC1, MUC5AC, and MUC6 in an amphicrine subtype of MTC. Review of the literature identified five other MTC cases with well-documented amphicrine features. Of these six cases, two were associated with MEN2B syndrome, and four had metastatic disease. Follow-up was available in three patients, and two died of disease. Recognition of this rare subtype of MTC may be of clinical interest given their frequent link to MEN2B syndrome and biological aggressiveness.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Amphicrine carcinoma; Amphicrine subtype medullary thyroid carcinoma; MEN2B syndrome; MUC1; MUC5AC; MUC6; Medullary thyroid carcinoma; MiNEN; RET; Radiology

Mesh:

Year:  2022        PMID: 35733030     DOI: 10.1007/s12022-022-09725-1

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   4.056


  23 in total

Review 1.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

2.  Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years.

Authors:  Reese W Randle; Courtney J Balentine; Glen E Leverson; Jeffrey A Havlena; Rebecca S Sippel; David F Schneider; Susan C Pitt
Journal:  Surgery       Date:  2016-11-11       Impact factor: 3.982

3.  Dedifferentiation of neoplastic cells in medullary thyroid carcinoma: report of a case.

Authors:  M Osaka; J Soga; Y Tamiya; T Suzuki
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

4.  Fine-needle aspiration biopsy of mucus-producing medullary carcinoma of thyroid: report of a case with cytologic, histologic, and ultrastructural correlations.

Authors:  A Haleem; M Akhtar; M A Ali; Z Iqbal
Journal:  Diagn Cytopathol       Date:  1990       Impact factor: 1.582

5.  Amphicrine medullary carcinoma of the thyroid with luminal differentiation: report of an immunohistochemical and ultrastructural study.

Authors:  H Dominguez-Malagon; V Macias-Martinez; H Molina-Cardenas; S Suster
Journal:  Ultrastruct Pathol       Date:  1997 Nov-Dec       Impact factor: 1.094

6.  Amphicrine--composite calcitonin and mucin-producing--carcinoma of the thyroid.

Authors:  R Golouh; M Us-Krasovec; M Auersperg; J Jancar; A Bondi; V Eusebi
Journal:  Ultrastruct Pathol       Date:  1985       Impact factor: 1.094

7.  Mucin production in medullary carcinoma of the thyroid.

Authors:  G S Zaatari; P E Saigo; A G Huvos
Journal:  Arch Pathol Lab Med       Date:  1983-02       Impact factor: 5.534

8.  Intracytoplasmic lumina in medullary carcinoma of the thyroid gland. Report of a case with cytologic and immunocytochemical features.

Authors:  Mitsuyuki Kinjo; Cyourei Yohena; Nobuyoshi Kunishima
Journal:  Acta Cytol       Date:  2003 Jul-Aug       Impact factor: 2.319

9.  Mucin in carcinomas of the thyroid.

Authors:  M L Mlynek; H J Richter; L D Leder
Journal:  Cancer       Date:  1985-12-01       Impact factor: 6.860

10.  Primary Benign and Malignant Thyroid Neoplasms With Signet Ring Cells: Cytologic, Histologic, and Molecular Features.

Authors:  Nada A Farhat; Ayse M Onenerk; Jeffrey F Krane; Dora Dias-Santagata; Peter M Sadow; William C Faquin
Journal:  Am J Clin Pathol       Date:  2017-09-01       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.